Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility

Molecular and Cellular Biology

Volumn 17, Issue 5, 1997, Pages 2550-2558

  Han, Innoc ^a   Kudlow, Jeffrey E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCOSAMINE; GLUCOSE; N ACETYLGLUCOSAMINE; PROTEASOME; TRANSCRIPTION FACTOR;

ARTICLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN STABILITY; REGULATORY MECHANISM;

EID: 0030907389     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.5.2550     Document Type: Article

References (52)

1. Aristarkhow, A., E. Eytan, A. Moghe, A. Admon, A. Hershko, and J. V. Ruderman. 1996. E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins. Proc. Natl. Acad. Sci. USA 93:4294-4299.
2. Azizkhan, J. C., D. E. Jensen, A. J. Pierce, and M. Wade. 1993. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expression 3:229-254.
3. Barrai, Y., S. Jentsch, and C. Mann. 1995. G1 cyclin turnover and nutrient uptake are controlled hy a common pathway in yeast. Genes Dev. 9:399-409.
4. Biggs, J. R., J. E. Kudlow, and A. S. Kraft. 1996. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271:901-906.
5. Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoter specific transcription factor Sp1. Science 234:47-52.
6. Chakraborty, A., D. Saha, A. Bose, M. Chatterjee, and N. K. Gupta. 1994. Regulation of eIF-2 α-subunit phosphorylation in reticulocyte lysate. Biochemistry 33:6700-6706.
7. Chen, L. I., T. Nishinaka, K. Kwan, I. Kitabayashi, K. Yokoyama, Y. H. F. Fu, S. Grunwald, and R. Chiu. 1994. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14:4380-4389.
8. Chou, T.-Y., C. V. Dang, and G. W. Hart. 1995. Glycosylation of the c-Myc transactivation domain. Proc. Natl. Acad. Sci. USA 92:4417-4421.
9. Chou, T. Y., G. W. Hart, and C. V. Dang. 1995. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270:18961-18965.
10. Ciechanover, A. 1994. The ubiquitin-proteosome proteolytic pathway. Cell 79:13-21.
11. Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069-1072.
12. Daniels, M. C., P. Kansal, T. Smith, A. J. Paterson, J. E. Kudlow, and D. A. McClain. 1993. Glucose regulation of transforming growth faclor-α expression mediated by products of hexosamine biosynthesis pathway. Mol. Endocrinol. 7:1041-1048.
13. Datta, B., D. Chakrabarti, A. L. Roy, and N. K. Gupta. 1988. Roles of a 67-kDa polypeptide in reversal of protein synthesis inhibition in heme-deficient reticulocyte lysate. Proc. Natl. Acad. Sci. USA 85:3324-3328.
14. 67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 α-subunit. J. Biol. Chem. 264:20620-20624.
15. Deshaies, R. J., V. Chau, and M. Kirschner. 1995. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J. 14:303-312.
16. The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:977-986.
17. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
18. Dynan, W. S., J. D. Safer, W. S. Lee, and R. Tjian. 1985. Transcription factor Sp1 recognizes promoter sequences from the monkey genome that are similar to the simian virus 40 promoter. Proc. Natl. Acad. Sci. USA 82:4915-4919.
19. Elias, S., B. Bercovich, C. Kahana, P. Coffino, M. Fischer, W. Hilt, D. H. Wolf, and A. Ciechanover. 1995. Degradation of ornithine decarboxylase by the mammalian and yeast 26S proteasome complexes requires all the components of the protease. Eur. J. Biochem. 229:276-283.
20. Fenteany, G., R. R. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731.
21. Han, I.-O., and J. E. Kudlow. Domain specific interaction between transcription factor Sp1 and nuclear pore protein p62. Submitted for publication.
22. Hochstrasser, M. 1996. Protein degradation or regulation: Ub the judge. Cell 84:813-815.
23. Horowitz, J. M., D. W. Yandell, S.-H. Park, S. Canning, P. Whyte, K. J. Buchovich, E. Harlow, R. A. Weinberg, and T. P. Dryja. 1989. Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937-940.
24. Ishii, H., M. R. Jirousek, D. Koya, C. Takagi, P. Xia, A. Clermont, S. E. Bursell, T. S. Kern, L. M. Ballas, W. F. Heath, L. E. Stramm, E. P. Feener, and G. L. King. 1996. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:728-731.
25. Jackson, S. P., J. J. MacDonald, S. Lees-Miller, and R. Tjian. 1990. GC-box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63:155-165
26. Jackson, S. P., and R. Tjian. 1988. O-glycosylation of eukaryotic transcription factors: implications for mechanism of transcriptional regulation. Cell 55:125-133.
27. Jariel-Encoutre, I., M. Patriat, F. Martin, S. Carillo, C. Salvat, and M. Piechaczyk. 1995. Ubiquitination is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J. Biol. Chem. 270:11623-11627.
28. Kadonaga, J. T., K. R. Carner, F. R. Masiarz, and R. Tjian. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079-1090.
29. Kadonaga, J. T., K. A. Jones, and R. Tjian. 1986. Promoter specific activation of RNA polymerase II by Sp1. Trends Biochem. Sci. 11:20-23.
30. Kato, J. Y., M. Matsuoka, K. Polyak, J. Massague, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496.
31. Kelly, W. G., M. E. Dahmus, and G. W. Hart. 1993. RNA polymerase II is a glycoprotein: modification of the C-terminal domain by O-GlcNAc. J. Biol. Chem. 268:10416-10424.
32. Lubas, W. A., M. Smith, C. M. Starr, and J. A. Hanover. 1995. Analysis of nuclear pore protein p62 glycosylation. Biochemistry 34:1686-1694.
33. McClain, D. A., A. J. Paterson, M. D. Roos, X. Wei, and J. E. Kudlow. 1992. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 89:8150-8154.
34. Measday, V., L. Moore, J. Ogas, M. Tyers, and B. Andrews. 1994. The PCL2 (ORFD)-Pho85 cyclin-dependent protein kinase complex: a cell cycle regulator in yeast. Science 266:1391-1395.
35. Moss, B. 1991. Vaccinia virus: a tool for research and vaccine development. Science 252:1662-1667.
36. Pugh, B. F., and R. Tjian. 1991. Transcription from a TATA-less promoter requires a multi-subunit TFIID complex. Genes Dev. 5:1935-1945.
37. Reason, A. J., H. R. Morris, M. Panico, R. Marais, R. H. Treisman, R. S. Haltiwanger, G. W. Hart, W. G. Kelly, and A. Dell. 1992. Localization of O-GlcNAc modification on the serum response transcription factor. J. Biol. Chem. 267:16911-16921.
38. Richter-Ruoff, B., and D. H. Wolf. 1993. Proteasome and cell cycle. Evidence for a regulatory role of the protease on mitotic cyclins in yeast. FEBS Lett. 336:34-36.
39. Roberts, A. B., M. A. Anzano, L. M. Wakefield, N. S. Roche, D. F. Stern, and M. B. Sporn. 1985. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82:119-123.
40. Roos, M. D., I. O. Han, A. J. Paterson, and J. E. Kudlow. 1996. Role of glucosamine synthesis in the stimulation of TGF-α gene transcription by glucose and EGF. Am. J. Physiol. 270:C803-C811.
41. Roos, M. D., and J. E. Kudlow. Unpublished results.
42. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for 1990s Nature 362:801-809.
43. Saffer, J. D., S. P. Jackson, and M. B. Annarella. 1991. Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11:2189-2199.
44. Saffer, J. D., S. P. Jackson, and S. J. Thurston. 1990. SV40 stimulates expression of the transacting factor Sp1 at the mRNA level. Genes Dev. 4:659-666.
45. Santos, R. C., N. C. Waters, C. L. Creasy, and L. W. Bergman. 1995. Structure-function relationships of the yeast cyclin-dependent kinase Pho85. Mol. Cell. Biol. 15:5482-5491.
46. Sayeski, P. P., and J. E. Kudlow. 1996. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcription. J. Biol. Chem. 271:15237-15243.
47. Seamon, K. B., and J. W. Daly. 1981. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7:201-224.
48. Shin, T. H., A. J. Paterson, J. H. Grant III, A. A. Meluch, and J. E. Kudlow. 1992. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor α expression. Mol. Cell. Biol. 12:3998-4006.
49. Snow, C. M., A. Senior, and L. Gerace. 1987. Monoclonal antibodies identify a group of nuclear pore complex proteins. J. Cell Biol. 104:1143-1156.
50. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
51. Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065-1069.
52. Yaglom, J., M. H. Linskens, S. Sadis, D. M. Rubin, B. Futcher, and D. Finley. 1995. p34Cdc28-mediated control of Cln3 cyclin degradation. Mol. Cell. Biol. 15:731-741.